Is metformin use associated with low mortality in patients with type 2 diabetes mellitus hospitalized for COVID-19? a multivariable and propensity score-adjusted meta-analysis.
Zhiyuan MaMahesh KrishnamurthyPublished in: PloS one (2023)
Our results suggest that there is a significant association between the reduction of in-hospital mortality and outpatient metformin therapy for type 2 diabetes mellitus in patients hospitalized for COVID-19.
Keyphrases
- coronavirus disease
- sars cov
- systematic review
- end stage renal disease
- ejection fraction
- newly diagnosed
- type diabetes
- randomized controlled trial
- cardiovascular events
- respiratory syndrome coronavirus
- meta analyses
- cardiovascular disease
- coronary artery disease
- glycemic control
- adipose tissue
- skeletal muscle
- risk factors